|
|
 |
|
Viewing report
|
|
|
|
Guide to Pharmaceutical Outsourcing in China: A Handbook for Pharmaceutical and Biotechnology Companies Planning to Outsource to China
JZMed Inc., March 2008, Pages: 180
As China has become one of the hottest areas for pharmaceutical and biopharmaceutical outsourcing, there is an urgent need for the Western pharma and biotech companies, in particular those small-sized ones who do not have sufficient internal resources to manage all steps of the outsourcing process, to have a complete collection of the information with regards to the current situation and service capabilities of the Chinese pharmaceutical outsourcing service providers. This guide is thus prepared to address these issues.
It provides answers to such questions as:
- Whether is it the right time to go to China for outsourcing?
- Who are those Chinese service providers?
- What can they do?
- How good is each of these individual Chinese CROs?
- Where are they located?
- How to approach them?
- How to ensure my outsourcing effort in China will be successful?
Besides, it also provides a step-by-step procedure for conducting pharmaceutical outsourcing in China. The Guide could also serve as a useful reference book for those executives in the pharmaceutical and biotechnology industries as well as in the financial investment industry who wish to have a complete understanding of what is really going on in the Chinese pharmaceutical industry and how this industry will develop in the near future.
Guide to Pharmaceutical Outsourcing in China - A Handbook for Pharmaceutical and Biotechnology Companies Planning to Outsource to China is concentrated on description of the current service capabilities of Chinese CROs and the step-by-step procedures of how to conduct and effectively manage the outsourcing activities in China, the two urgent issues that at present need to be addressed for pharmaceutical and biotech companies that either have potential interests or are in planning to outsource to China.
The main features of the Guide include:
- A complete and detailed analysis of the current service capabilities of Chinese CROs in each outsourcing area and the strategies of how to choose an ideal CRO that meets outsourcing requirements.
- An in-depth and objective evaluation of the potential risks for outsourcing in China at present time and detailed comparisons of the potential risks against apparent rewards.
- A comprehensive list of suggestions of proper actions the outsourcing companies, in particular the small-sized biotech companies, should take in order to minimize the risks and maximize the benefits from their outsourcing effort in China.
- A complete collection of information of more than 60 Chinese CROs that have capabilities to conduct contract research in drug discovery and development. This information includes: the service scope/capability of each Chinese CRO, the author comments on the strengths of their service capability, the CRO company founder's background and the year the CRO was founded, the current number of technical employees (including the approximate percentage of senior (Ph.D. level) scientists) in each CRO company, as well as the complete contact information including street and e-mail addresses, phone and fax numbers as well as websites, etc.
- Detailed comparisons between the Indian pharmaceutical outsourcing service industry and the Chinese pharmaceutical outsourcing service industry, including the strengths and weakness of each country in each service area. Based on the detailed analysis of the service features of each country, the Guide further provides the suggestions to Western companies of where to choose a suitable CRO for their outsourcing projects.
- Valuable insights into the development trend of the world pharmaceutical outsourcing industry, and, based on this trend, a brave but reasonable prediction of the future development trend of the Chinese pharmaceutical outsourcing service industry in the next 5 to 10 years.
The Guide intends to target the vast pool of readers in pharmaceutical and biotech industry, in particular those executives in the small to medium-sized companies who have urgent needs to outsource their R&D and/or manufacturing tasks but have limited information resources to understand the Chinese outsourcing service industry (its providers and service capabilities). To better serve these readers, the Guide has also sorted the Chinese CROs according to their service capabilities as well as geographic locations in China. The Guide is well defined in nine chapters and more than 180 pages (including close to 20 tables and figures).
This Guide differs from any of the market research reports and/or books already published in this field. It does not intend to provide the complete information about the current development situation of the Chinese pharmaceutical industry. Instead, it focuses on the specific topics in the entire, complicated process of pharmaceutical outsourcing in China. The Guide is written based on the ten years experience of mine in the pharmaceutical outsourcing industry and a broad survey on the Chinese CROs conducted most recently as well as my knowledge about the Chinese pharmaceutical industry accumulated over last two decades.
Based on the current hot situation of the pharmaceutical outsourcing in China, I believe it is the perfect time to publish such a guide. It will certainly provide enormous help in a timely fashion to many pharma and biotech companies that wish to outsource their costly drug research, development and manufacturing work to China.
** Hard copy versions available on request **
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
200 China-based Best CROs and CMOs
China�s Attraction and Strategies to Work with It: Analysis of Best Strategies for Western Pharmaceutical and Biotech Companies to Partner with Chinese Pharmaceutical Companies
China Pharma Outsourcing Market By 2015
Comparison of Pharma Outsourcing between China and India
Top 100 Best Pharma Outsourcing Service Providers in China and India
A Guide to Evaluating and Choosing CROs
2008 Report for the Investigation of the Chinese Medical and Pharmaceutical CRO Market
Pharmaceutical Outsourcing in Drug Discovery and Development: Contract Research Opportunity in India
Pharmaceutical Outsourcing Strategies: Market Expansion, Offshoring and Strategic Management in the CRO and CMO Marketplace
Outsourcing Drug Discovery to China and India
Intellectual Property and Outsourcing in China: Minimizing Risk whilst Maximizing Return on Investment
Strategic Clinical Sourcing: Managing Costs and CROs
|
|
|
|
